Figure 2.
Phenotypic and functional characteristics of spike re-challenged and ex vivo expanded CoV-2-STs from BNT162b2 vaccinees. Panel A Cytotoxic activity of CoV-2-STs expanded 1-month (blue dots) and 8-months (orange dots) post vaccination against autologous, unmutated spike-pulsed phytohaemagglutinin (PHA) blasts. Regression lines per group and ± SE ribbons are shown. Panel B Number of interferon-γ secreting CoV-2-STs expanded 8-months post vaccination after pulsing with the unmutated SARS-CoV-2 spike antigen, B.1.1.7 (alpha), B.1.351 (beta) and B.1.617.2 (delta) SARS-CoV-2 variants. Boxplots denote median and quartile bounds. Whiskers are placed at 1.5x interquartile range. Panel C Cytotoxic activity of CoV-2-STs expanded 8-months post vaccination against autologous, PHA blasts pulsed with the unmutated spike antigen (orange dots) or the delta variant (green dots). Regression lines per group and ± SE ribbons are shown. Panel D Immunophenotypic profile of CoV-2-STs expanded 1-month and 8-months post vaccination. CM: central memory; EM: effector memory.
